EP4351582
COMBINATION OF A PARTICULAR BRAF INHIBITOR (PARADOX BREAKER) AND A PD-1 AXIS BINDING ANTAGONIST FOR USE IN THE TREATMENT OF CANCER
:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi:
7.6.2022:
8.10.2025:
22733341.6
:
6.6.2042:
6.6.2026
:
COMBINATION OF A PARTICULAR BRAF INHIBITOR (PARADOX BREAKER) AND A PD-1 AXIS BINDING ANTAGONIST FOR USE IN THE TREATMENT OF CANCER
7.6.2022
8.10.2025
6.6.2026
:
F. Hoffmann-La Roche AG:
Grenzacherstrasse 124, 4070 Basel, CH
:
ECKMANN, Jan:
82377 Penzberg, DE
:
FRIESS, Thomas:
82377 Penzberg, DE
:
HERTING, Frank:
82377 Penzberg, DE
:
PETTAZZONI, Piergiorgio Francesco Tommaso:
4070 Basel, CH
:
WICHMANN, Juergen:
4070 Basel, CH
:
21178462:
9.6.2021:
EP
:
22157499:
18.2.2022:
EP
:
EP2022065373:
7.6.2022
:
A61K 31/517, A61P 35/00, A61K 45/06, A61K 39/395, C07K 16/28